☰

David Blum - Publications

Affiliations: 
Clinical Research & Medical Affairs Biodelivery Sciences International, Raleigh, NC, United States 
Area:
drug development, pain, other areas
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Mintzer S, Constantino T, Gidal B, Bhargava P, Grinnell T, Blum D. Markers of bone and lipid metabolism with eslicarbazepine acetate monotherapy. Epilepsy Research. 158: 106216. PMID 31675622 DOI: 10.1016/j.eplepsyres.2019.106216  0.507
2019 Chung S, Sinha SR, Shah A, Stern JM, Cheng H, Jung J, Grinnell T, Blum D. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures. Epilepsy Research. 153: 59-65. PMID 30999260 DOI: 10.1016/j.eplepsyres.2019.03.018  0.456
2018 Abou-Khalil B, Klein P, Shah A, Ryvlin P, Specchio LM, Gama H, Rocha F, Blum D, Grinnell T, Cheng H, Jung J. Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures. Epilepsy Research. 147: 80-86. PMID 30278294 DOI: 10.1016/j.eplepsyres.2018.08.011  0.305
2018 Mintzer S, Wechsler RT, Rogin JB, Gidal BE, Schwab M, Ben-Menachem E, Carreño M, da Silva PS, Moreira J, Li Y, Blum D, Grinnell T. Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs. Epilepsy Research. 141: 83-89. PMID 29499473 DOI: 10.1016/j.eplepsyres.2018.02.001  0.581
2018 Pazdera L, Sperling MR, Harvey JH, Sam MC, Strom LA, Blum D, Grinnell T, Cheng H. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. Epilepsia. PMID 29450890 DOI: 10.1111/epi.14014  0.442
2017 Gidal BE, Mintzer S, Schwab M, Schutz R, Kharidia J, Blum D, Grinnell T, Sunkaraneni S. Evidence for a pharmacokinetic interaction between eslicarbazepine and rosuvastatin: Potential effects on xenobiotic transporters. Epilepsy Research. 135: 64-70. PMID 28624574 DOI: 10.1016/j.eplepsyres.2017.05.005  0.566
2016 French JA, Mintzer S, Perucca E, Blum DE, Cramer JA, Messenheimer JA, Baulac M. Reflections on monotherapy trials for epilepsy - Authors' reply. The Lancet. Neurology. 15: 657-8. PMID 27302226 DOI: 10.1016/S1474-4422(16)00119-8  0.554
2016 Sperling MR, French J, Jacobson MP, Pazdera L, Gough M, Cheng H, Grinnell T, Blum D. Conversion to eslicarbazepine acetate monotherapy: A pooled analysis of 2 phase III studies. Neurology. PMID 26911639 DOI: 10.1212/WNL.0000000000002497  0.344
2015 Mintzer S, French JA, Perucca E, Cramer JA, Messenheimer JA, Blum DE, Rogawski MA, Baulac M. Is a separate monotherapy indication warranted for antiepileptic drugs? The Lancet. Neurology. 14: 1229-40. PMID 26581972 DOI: 10.1016/S1474-4422(15)00229-X  0.563
2015 Sperling MR, Harvey J, Grinnell T, Cheng H, Blum D. Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America. Epilepsia. 56: 546-55. PMID 25689448 DOI: 10.1111/epi.12934  0.447
2015 Sperling MR, Abou-Khalil B, Harvey J, Rogin JB, Biraben A, Galimberti CA, Kowacs PA, Hong SB, Cheng H, Blum D, Nunes T, Soares-da-Silva P. Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial. Epilepsia. 56: 244-53. PMID 25528898 DOI: 10.1111/epi.12894  0.435
Show low-probability matches.